不同途径给表阿霉素及联用血液灌流的临床意义
肝肿瘤,药物疗法;表柔比星,投药和剂量;表柔比星,药代动力学;血液灌注,项目负责人,Correspondenceto,ClinicalSignificanceofepidoxorubicinadministration,viaperipheralveinandregionalarteriaandcombination,withdireathemoper
1广东省东莞市桥头医院内科 5117382重庆医科大学附属一院消化科 重庆市 630042
刘宇虎,男,1963-06-01生,四川省越西县人,汉族. 1985年重庆医科大学本科毕业,1992年重庆医科大学消化内科硕士研究生毕业,主治医师,主要从事内镜诊治和胃肠、肝病诊治和研究工作,发表论文12篇.
项目负责人 刘宇虎,511738,广东省东莞市桥头医院内科.
Correspondence to Yu-Hu Liu, Department of Internal Medicine, Qiaotou Hospital, Dongguan 511738, Guangdong Province, China
Tel. +86·769·3341363
收稿日期 1998-01-31
Clinical Significance of epidoxorubicin administration via peripheral vein and regional arteria and combination
with direat hemoperfusion
Yu-Hu Liu1 and Zhen Niu2
1Department of Internal Medicine, Qiaotou Hospital, Dongguan 511738, Guangdong Province, China
2Department of Gastroenterology, The First Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 630042, China
Abstract
AIM To evaluate the value of infusion epidoxorubin (EPI) by different ways and the effect of combined direct hemoperfusion (DHP).
METHODS EPI plasma concentration changes were monitored during continuous administration of drug EPI via regional intraarterial of liver (Group A) and peripheral intravenous (Group B) for 30 minutes, with or without diacetylchitin-coated resin (DAC-resin) DHP in Group B in patients with liver cancer. ......
您现在查看是摘要页,全文长 10272 字符。